This shared component flags when a patient has been issued six or more Short-Acting Beta-Agonist (SABA) inhalers (e.g. salbutamol) in the past 6 months. It serves as a key marker of poor asthma control and risk of exacerbation.
This alert appears when:
A patient has a coded asthma diagnosis
Six or more SABA inhalers have been prescribed in the last 6 months
Field | Purpose |
| Review of SABA Use | Confirm discussion with patient about overuse and associated risk |
| Contributing Factors | Document reasons for overuse (e.g. poor technique, non-adherence to preventer) |
| Plan for Adjustment | Record any therapy changes, referrals, or self-management updates |
| Patient Education Given | Confirm discussion of safe inhaler use and triggers |
⚠️ Excessive SABA use is associated with increased risk of hospitalisation and asthma-related death.
NICE and NRAD recommend <3 SABA inhalers per year for well-controlled asthma
≥6 in 6 months suggests suboptimal control
Often indicates preventer underuse, poor adherence, or poorly understood asthma
“How often are you using your reliever inhaler?”
“Have you been needing it more than usual lately?”
“Do you feel it’s helping, or are symptoms still breaking through?”
This component acts as a safety net to detect and address high-risk reliever use — ensuring timely intervention and reducing preventable asthma deterioration.